CHARISMA: The antiplatelet saga continues

Stroke

Volumn 37, Issue 9, 2006, Pages 2428-2429

  Norris, John W ^a   Barnett, Henry J ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ARTICLE; BLEEDING; BRAIN INFARCTION; CLINICAL TRIAL; HEART INFARCTION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VASCULAR DISEASE;

ATHEROSCLEROSIS; CLINICAL TRIALS; HUMANS; ISCHEMIA; PLATELET AGGREGATION INHIBITORS; THROMBOSIS; TICLOPIDINE; TREATMENT FAILURE;

EID: 33748357329     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000236037.87109.fc     Document Type: Article

References (6)

1. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ. 2002;324:71-88.
2. CAPRIE steering committee. A randomised blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet. 1996;348:1329-1339.
3. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. N Engl J Med. 2001;345:494-502.
4. Steinhubl SR, Berger PB, Mann JT; for the CREDO investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomised controlled trial. JAMA. 2002;288:2411-2420.
5. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischaemic attack in high risk patients (MATCH) :a randomised, double blind, placebo controlled trial. Lancet. 2004;364:331-337.
6. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706-1717.